vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Janus International Group, Inc. (JBI). Click either name above to swap in a different company.
Janus International Group, Inc. is the larger business by last-quarter revenue ($219.3M vs $207.8M, roughly 1.1× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 6.9%, a 50.4% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $8.3M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Janus Henderson is a British-American global asset management group headquartered in the City of London, United Kingdom. It offers a range of financial products to individuals, intermediary advisors, and institutional investors globally under the trade name Janus Henderson Investors.
IDYA vs JBI — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $219.3M |
| Net Profit | $119.2M | $15.2M |
| Gross Margin | — | 39.1% |
| Operating Margin | 52.2% | 13.4% |
| Net Margin | 57.4% | 6.9% |
| Revenue YoY | — | -4.7% |
| Net Profit YoY | 330.1% | 28.8% |
| EPS (diluted) | $1.33 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $207.8M | $219.3M | ||
| Q2 25 | — | $228.1M | ||
| Q1 25 | — | $210.5M | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | $0 | $230.1M | ||
| Q2 24 | $0 | $248.4M | ||
| Q1 24 | $0 | $254.5M | ||
| Q4 23 | — | $263.8M |
| Q3 25 | $119.2M | $15.2M | ||
| Q2 25 | — | $20.7M | ||
| Q1 25 | — | $10.8M | ||
| Q4 24 | — | $300.0K | ||
| Q3 24 | $-51.8M | $11.8M | ||
| Q2 24 | $-52.8M | $27.6M | ||
| Q1 24 | $-39.6M | $30.7M | ||
| Q4 23 | — | $35.7M |
| Q3 25 | — | 39.1% | ||
| Q2 25 | — | 40.9% | ||
| Q1 25 | — | 38.9% | ||
| Q4 24 | — | 37.8% | ||
| Q3 24 | — | 39.6% | ||
| Q2 24 | — | 43.9% | ||
| Q1 24 | — | 43.4% | ||
| Q4 23 | — | 43.4% |
| Q3 25 | 52.2% | 13.4% | ||
| Q2 25 | — | 15.8% | ||
| Q1 25 | — | 12.0% | ||
| Q4 24 | — | 5.5% | ||
| Q3 24 | — | 11.6% | ||
| Q2 24 | — | 20.8% | ||
| Q1 24 | — | 21.8% | ||
| Q4 23 | — | 24.2% |
| Q3 25 | 57.4% | 6.9% | ||
| Q2 25 | — | 9.1% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 5.1% | ||
| Q2 24 | — | 11.1% | ||
| Q1 24 | — | 12.1% | ||
| Q4 23 | — | 13.5% |
| Q3 25 | $1.33 | $0.11 | ||
| Q2 25 | — | $0.15 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-0.60 | $0.08 | ||
| Q2 24 | $-0.68 | $0.19 | ||
| Q1 24 | $-0.53 | $0.21 | ||
| Q4 23 | — | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $560.8M |
| Total Assets | $1.2B | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $786.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $920.0M | $102.1M | ||
| Q2 24 | $701.7M | $110.1M | ||
| Q1 24 | $698.8M | — | ||
| Q4 23 | — | $171.7M |
| Q3 25 | $1.1B | $560.8M | ||
| Q2 25 | — | $543.8M | ||
| Q1 25 | — | $526.8M | ||
| Q4 24 | — | $518.8M | ||
| Q3 24 | $1.2B | $526.6M | ||
| Q2 24 | $931.7M | $556.3M | ||
| Q1 24 | $935.3M | $535.4M | ||
| Q4 23 | — | $519.6M |
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $1.2B | $1.3B | ||
| Q2 24 | $973.7M | $1.3B | ||
| Q1 24 | $961.5M | $1.4B | ||
| Q4 23 | — | $1.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $15.0M |
| Free Cash FlowOCF − Capex | $142.2M | $8.3M |
| FCF MarginFCF / Revenue | 68.4% | 3.8% |
| Capex IntensityCapex / Revenue | 0.0% | 3.1% |
| Cash ConversionOCF / Net Profit | 1.19× | 0.99× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $140.1M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $142.2M | $15.0M | ||
| Q2 25 | — | $51.4M | ||
| Q1 25 | — | $48.3M | ||
| Q4 24 | — | $51.4M | ||
| Q3 24 | $-49.2M | $43.0M | ||
| Q2 24 | $-32.9M | $31.0M | ||
| Q1 24 | $-43.8M | $28.6M | ||
| Q4 23 | — | $68.5M |
| Q3 25 | $142.2M | $8.3M | ||
| Q2 25 | — | $44.6M | ||
| Q1 25 | — | $41.9M | ||
| Q4 24 | — | $45.3M | ||
| Q3 24 | $-49.7M | $39.3M | ||
| Q2 24 | $-33.9M | $25.3M | ||
| Q1 24 | $-45.1M | $24.0M | ||
| Q4 23 | — | $63.0M |
| Q3 25 | 68.4% | 3.8% | ||
| Q2 25 | — | 19.6% | ||
| Q1 25 | — | 19.9% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 17.1% | ||
| Q2 24 | — | 10.2% | ||
| Q1 24 | — | 9.4% | ||
| Q4 23 | — | 23.9% |
| Q3 25 | 0.0% | 3.1% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 1.8% | ||
| Q4 23 | — | 2.1% |
| Q3 25 | 1.19× | 0.99× | ||
| Q2 25 | — | 2.48× | ||
| Q1 25 | — | 4.47× | ||
| Q4 24 | — | 171.33× | ||
| Q3 24 | — | 3.64× | ||
| Q2 24 | — | 1.12× | ||
| Q1 24 | — | 0.93× | ||
| Q4 23 | — | 1.92× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
JBI
| Self Storage New Construction | $72.3M | 33% |
| Commercial And Others | $65.5M | 30% |
| Self Storage R3 | $54.0M | 25% |
| Transferred At Point In Time | $15.5M | 7% |
| Transferred Over Time | $12.8M | 6% |
